Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

GLORIMARI NIEVES

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner

NPI
1700420312
CMS profile
10671404
Location
MIAMI, FL

General Payments · PY2021–2024

$2,516.55

  • Reported across 88 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$842.93

40 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $842.93 40

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $510.05 7
PY2022 $398.33 10
PY2023 $765.24 31
PY2024 $842.93 40

Payment records · PY2024 (40)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $20.66 05/21/2024 Food and Beverage Undisputed 01/23/2026 1104268971 CMS
AstraZeneca Pharmaceuticals LP $24.94 06/08/2024 Food and Beverage Undisputed 01/23/2026 1104290550 CMS
AstraZeneca Pharmaceuticals LP $29.55 10/28/2024 Food and Beverage Undisputed 01/23/2026 1105559170 CMS
AstraZeneca Pharmaceuticals LP $27.28 11/19/2024 Food and Beverage Undisputed 01/23/2026 1105429296 CMS
Daiichi Sankyo Inc. $23.50 06/21/2024 Food and Beverage Undisputed 01/23/2026 1089462944 CMS
Daiichi Sankyo Inc. $29.41 10/29/2024 Food and Beverage Undisputed 01/23/2026 1089462942 CMS
Genentech USA, Inc. $18.75 07/24/2024 Food and Beverage Undisputed 01/23/2026 1133159512 CMS
Genentech USA, Inc. $22.33 09/16/2024 Food and Beverage Undisputed 01/23/2026 1133159516 CMS
Janssen Biotech, Inc. $28.08 09/05/2024 Food and Beverage Undisputed 01/23/2026 1078448496 CMS
Lilly USA, LLC $17.78 02/13/2024 Food and Beverage Undisputed 01/23/2026 1135691542 CMS
Lilly USA, LLC $16.60 03/15/2024 Food and Beverage Undisputed 01/23/2026 1135661319 CMS
Lilly USA, LLC $19.26 05/07/2024 Food and Beverage Undisputed 01/23/2026 1135639592 CMS
Lilly USA, LLC $16.94 10/30/2024 Food and Beverage Undisputed 01/23/2026 1135661317 CMS
Lilly USA, LLC $19.51 11/15/2024 Food and Beverage Undisputed 01/23/2026 1135639594 CMS
Merck Sharp & Dohme LLC $18.82 01/16/2024 Food and Beverage Undisputed 01/23/2026 1141615670 CMS
Merck Sharp & Dohme LLC $19.27 02/05/2024 Food and Beverage Undisputed 01/23/2026 1141842569 CMS
Merck Sharp & Dohme LLC $19.84 03/14/2024 Food and Beverage Undisputed 01/23/2026 1141615668 CMS
Merck Sharp & Dohme LLC $15.30 03/19/2024 Food and Beverage Undisputed 01/23/2026 1141615564 CMS
Merck Sharp & Dohme LLC $23.29 05/09/2024 Food and Beverage Undisputed 01/23/2026 1141615674 CMS
Merck Sharp & Dohme LLC $20.20 05/14/2024 Food and Beverage Undisputed 01/23/2026 1141615566 CMS
Merck Sharp & Dohme LLC $26.28 06/25/2024 Food and Beverage Undisputed 01/23/2026 1141918238 CMS
Merck Sharp & Dohme LLC $19.51 12/13/2024 Food and Beverage Undisputed 01/23/2026 1141615672 CMS
Myriad Genetic Laboratories, Inc. $27.07 04/30/2024 Food and Beverage Undisputed 01/23/2026 1152549386 CMS
Novartis Pharmaceuticals Corporation $14.69 09/30/2024 Food and Beverage Undisputed 01/23/2026 1087043352 CMS
PFIZER INC. $17.94 01/23/2024 Food and Beverage Undisputed 01/23/2026 1130950185 CMS
PFIZER INC. $17.37 02/09/2024 Food and Beverage Undisputed 01/23/2026 1131072786 CMS
PFIZER INC. $16.96 04/15/2024 Food and Beverage Undisputed 01/23/2026 1131311524 CMS
PFIZER INC. $19.32 04/16/2024 Food and Beverage Undisputed 01/23/2026 1131397653 CMS
PFIZER INC. $14.58 06/14/2024 Food and Beverage Undisputed 01/23/2026 1131609634 CMS
PFIZER INC. $20.58 07/02/2024 Food and Beverage Undisputed 01/23/2026 1131788903 CMS
Stemline Therapeutics Inc. $22.04 12/03/2024 Food and Beverage Undisputed 01/23/2026 1142967775 CMS
Tempus AI, Inc $19.99 08/28/2024 Food and Beverage Undisputed 01/23/2026 1150185178 CMS
Tempus AI, Inc $23.31 09/03/2024 Food and Beverage Undisputed 01/23/2026 1150185180 CMS
TerSera Therapeutics LLC $26.43 01/31/2024 Food and Beverage Undisputed 01/23/2026 1144721125 CMS
TerSera Therapeutics LLC $31.47 03/05/2024 Food and Beverage Undisputed 01/23/2026 1144721127 CMS
TerSera Therapeutics LLC $29.50 05/24/2024 Food and Beverage Undisputed 01/23/2026 1144721129 CMS
TerSera Therapeutics LLC $0.42 05/24/2024 Food and Beverage Undisputed 01/23/2026 1144721131 CMS
TerSera Therapeutics LLC $30.52 10/24/2024 Food and Beverage Undisputed 01/23/2026 1144721133 CMS
TerSera Therapeutics LLC $3.14 12/02/2024 Food and Beverage Undisputed 01/23/2026 1144721135 CMS
TerSera Therapeutics LLC $30.50 12/02/2024 Food and Beverage Undisputed 01/23/2026 1144721137 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.